| 摘要 |
<p>The present invention relates to a method for evaluating bioactivity in a simulated body fluid from a calcium solution-derived calcium silicate-based compound. More specifically, the present invention relates to a method for evaluating bioactivity in a simulated body fluid from a calcium solution-derived calcium silicate-based compound, wherein a simulated body fluid is produced, and a calcium solution-derived amorphous calcium silicate compound is deposited in the simulated body fluid.</p> |
